October 2026 recommendations about add-on reimbursement for medical devices in France

The French National Authority for Health (HAS) releases recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) based on assessments by the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). 

The CNEDiMTS evaluation process begins with assessing the clinical (actual) benefit (Service Attendu, SA), which is classified as either sufficient or insufficient. Only devices with a sufficient clinical benefit are eligible for inclusion in the LPPR. If deemed sufficient, the clinical added value (Amélioration du Service Attendu, ASA) is then graded from I (major) to V (absent) for the claimed indications, influencing pricing decisions.

In October 2026, favorable opinions were published on add-on reimbursement for four new medical devices in the peripheral vascular and orthopedics fields, as well as extending indications for three registered devices in the cardiovascular, neurovascular, and neuromodulation fields.

Some examples of new devices are provided below:

• Neo EDE custom-made hybrid vascular prosthesis (application for registration; sufficient actual benefit; level V clinical added value compared to the E-Vita Open Neo hybrid vascular prosthesis);
• ACORN TRASER dual-mobility acetabular cup consisting of a cementless cup and a conventional polyethylene insert (application for registration; sufficient actual benefit; level V clinical added value compared to single-mobility acetabular cups with a conventional polyethylene insert).

This news is just one of about 300 market access news and updates collected by our team in the premium subscription service MTRC Access Intelligence every week from more than 80 organizations. Access our paid service to stay on top of all developments, specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, six-week, no-obligation trial.